The present disclosure is directed to a method for screening
signal peptides for efficient expression and
secretion of
heterologous polypeptides in mammalian cells, comprising: providing a
pool of viral expression vectors encoding a polypeptide of interest comprising a variety of candidate
signal peptides, wherein each viral
expression vector of the
pool comprises at least a
polynucleotide encoding a
fusion protein, the
polynucleotide comprising: (i) a
promoter, (ii) a sequence encoding a
signal peptide, (iii) a sequence encoding a polypeptide of interest, (iv) optionally, a sequence encoding an
epitope tag, and (v) a sequence encoding a C-terminal
signal peptide for glycosylphosphatidylinositol (GPI) attachment or a sequence encoding a
transmembrane domain; hosting the
viral vector pool such that each host
cell is preferably transformed with only one
viral vector from the pool on average. The method includes the steps of transforming a host
cell; expressing the
fusion protein in the host
cell to produce a
fusion protein that is anchored to the host cell surface by a GPI or a
transmembrane domain of the fusion
protein; contacting the host cell with a first binding
reagent, preferably an
antibody that specifically binds to the target polypeptide; or, if an
epitope tag is present in the fusion
protein, a first binding
reagent that specifically binds to the
epitope tag; contacting the host cell with the first binding
reagent, which may optionally be labeled with a fluorescent
label or other detection means; dividing the transformed host cells into at least two groups based on the fluorescent properties of each host cell; and performing next-generation sequencing on the group of host cells that show the most efficient
fusion protein expression to identify the optimal
signal peptide for the target polypeptide in the host cell. The present disclosure is also directed to the vector, host cell, or
DNA library used in the method.